Genetic inflammatory or rheumatoid-like osteoarthropathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:498445
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Genetic inflammatory or rheumatoid-like osteoarthropathy (Orphanet code 498445) is a rare inherited condition that causes ongoing inflammation in the joints, leading to pain, swelling, and joint damage that looks similar to rheumatoid arthritis. Unlike common arthritis, this condition is caused by changes (mutations) in specific genes that disrupt how the immune system controls inflammation in and around the joints. Because the root cause is genetic, symptoms often start earlier in life than typical arthritis and may not respond well to standard arthritis treatments. The condition affects the joints throughout the body, most often causing stiffness, swelling, and pain that can come and go or be constant. Over time, the ongoing inflammation can damage the cartilage and bone inside the joints, making movement harder. Some people also experience symptoms outside the joints, such as skin changes, eye inflammation, or fever episodes, depending on the specific gene involved. Treatment focuses on reducing inflammation and protecting the joints from further damage. Anti-inflammatory medicines, disease-modifying drugs, and biologic therapies (medicines that target specific parts of the immune system) are the main tools doctors use. Because this is a genetic condition, a team of specialists including rheumatologists and clinical geneticists is usually needed to manage care effectively. Research into targeted therapies is ongoing, offering hope for better treatments in the future.

Key symptoms:

Joint pain and tendernessJoint swelling and warmthMorning stiffness that lasts more than an hourReduced range of motion in affected jointsFatigue and low energyRecurrent fever episodesSkin rashes or changes near affected jointsEye redness or inflammation (uveitis)Bone erosion or joint deformity over timeMuscle weakness around inflamed joints

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Genetic inflammatory or rheumatoid-like osteoarthropathy.

View clinical trials →

No actively recruiting trials found for Genetic inflammatory or rheumatoid-like osteoarthropathy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Genetic inflammatory or rheumatoid-like osteoarthropathy community →

No specialists are currently listed for Genetic inflammatory or rheumatoid-like osteoarthropathy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Genetic inflammatory or rheumatoid-like osteoarthropathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Genetic inflammatory or rheumatoid-like osteoarthropathyForum →

No community posts yet. Be the first to share your experience with Genetic inflammatory or rheumatoid-like osteoarthropathy.

Start the conversation →

Latest news about Genetic inflammatory or rheumatoid-like osteoarthropathy

No recent news articles for Genetic inflammatory or rheumatoid-like osteoarthropathy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific gene is causing my condition, and what does that mean for my treatment options?,What type of genetic testing should I have, and should my family members be tested too?,Which biologic or DMARD therapy is most likely to work for my specific genetic subtype?,How will we know if my treatment is working, and what are the signs that we need to change it?,What are the long-term risks of the medications you are recommending, especially for infections?,Are there any clinical trials I might be eligible for?,What lifestyle changes — such as exercise, diet, or joint protection strategies — can help me manage my symptoms?

Common questions about Genetic inflammatory or rheumatoid-like osteoarthropathy

What is Genetic inflammatory or rheumatoid-like osteoarthropathy?

Genetic inflammatory or rheumatoid-like osteoarthropathy (Orphanet code 498445) is a rare inherited condition that causes ongoing inflammation in the joints, leading to pain, swelling, and joint damage that looks similar to rheumatoid arthritis. Unlike common arthritis, this condition is caused by changes (mutations) in specific genes that disrupt how the immune system controls inflammation in and around the joints. Because the root cause is genetic, symptoms often start earlier in life than typical arthritis and may not respond well to standard arthritis treatments. The condition affects the